PIK3CA and colorectal carcinoma: This was demonstrated by Liao et al., who found that aspirin use after CRC diagnosis significantly improved CRC-specific survival in patients with PIK3CA-mutated CRCs (HR = 0.18; 95% CI: 0.06–0.61, p < 0.001).